Medicine to treat babies and infants suffering from malaria has been approved for the first time and is expected to be rolled out in Africa within weeks. Malaria treatment for infants weighing less ...

Add Yahoo as a preferred source to see more of our stories on Google. Spread largely by mosquitos, Malaria causes a fever, headaches, confusion and muscle pains among other symptoms and can be fatal.

The first-ever treatment for malaria in young babies and infants has been approved. On Tuesday, Novartis announced it had received approval for the treatment, Coartem Baby (known as Riamet Baby in ...

The first malaria treatment for babies and very young children of 2 months up to 5 years was approved for use by Swiss agency for therapeutic products, Swissmedic, in early July 2025. Until now, ...

Artesunate AMIVAS is now available for purchase across Europe and U.K. through Nordic Prime of Denmark. Artesunate AMIVAS, approved by EU Commission and U.K.’s Medicine and Healthcare Product ...

Swiss medical authorities have approved the first drug suitable to treat malaria in babies and very young children. Eight African countries that participated in clinical trials are now poised to ...

Malaria is a life-threatening disease that is transferred by mosquito bites. Interestingly, a specific type of mosquito can carry the disease. The transfer of the parasite to humans travels to the ...

Pharmacologist, physician, and researcher who transformed malaria treatment. Born in London, UK, on March 13, 1951, he died of cancer in Oxford, UK, on Feb 1, 2026, aged 74 years.

NEW YORK — Researchers on Wednesday reported two promising new approaches to counteract malaria’s growing resistance to medication — one involving a new class of drugs. Switzerland-based Novartis ...

For the first time in 20 years, malaria is spreading locally within the United States. Seven cases of malaria, a serious disease caused by a parasite that commonly infects a certain type of mosquito, ...

The first malaria drug for newborn babies and those weighing less than 11 pounds has been approved by Swiss medical authorities in a move that could fill a treatment gap for some of those most ...